𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The cancer-testis antigen NY-ESO-1 is highly expressed in myxoid and round cell subset of liposarcomas

✍ Scribed by Hemminger, Jessica A; Ewart Toland, Amanda; Scharschmidt, Thomas J; Mayerson, Joel L; Kraybill, William G; Guttridge, Denis C; Iwenofu, O Hans

Book ID
119971301
Publisher
Nature Publishing Group
Year
2012
Tongue
English
Weight
325 KB
Volume
26
Category
Article
ISSN
0893-3952

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

High expression of cancer testis antigen
High expression of cancer testis antigens MAGE-A, MAGE-C1/CT7, MAGE-C2/CT10, NY-ESO-1, and gage in advanced squamous cell carcinoma of the larynx
✍ David L. A. Figueiredo; Rui C. M. Mamede; Giulio C. Spagnoli; Wilson A. Silva Jr πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 395 KB πŸ‘ 1 views

## Abstract ## __Background.__ Despite diagnostic and therapeutic advances in head and neck cancer, the 5‐year survival of patients with laryngeal cancer has not improved in the last 30 years. Several recent studies indicate that specific targets for immunotherapeutic approaches can be useful in t

A phase I study of vaccination with NY-E
A phase I study of vaccination with NY-ESO-1f peptide mixed with Picibanil OK-432 and Montanide ISA-51 in patients with cancers expressing the NY-ESO-1 antigen
✍ Kazuhiro Kakimi; Midori Isobe; Akiko Uenaka; Hisashi Wada; Eiichi Sato; Yuichiro πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 French βš– 656 KB

## Abstract We conducted a phase I clinical trial of a cancer vaccine using a 20‐mer NY‐ESO‐1f peptide (NY‐ESO‐1 91–110) that includes multiple epitopes recognized by antibodies, and CD4 and CD8 T cells. Ten patients were immunized with 600 ΞΌg of NY‐ESO‐1f peptide mixed with 0.2 KE Picibanil OK‐432